Estée Lauder is in talks to merge with Puig amid ongoing turnaround plan
Estée Lauder said Monday the company is in talks to potentially merge with Spanish beauty company Puig....
Author : Douglas L. Grider
Toyota to invest $1 billion to increase U.S. production in Kentucky, Indiana plants
Toyota on Monday announced $1 billion in investments in two U.S. plants as part of a plan to invest up to $10 billion domestically over...
‘This is insane.’ Long lines plague U.S. airports as TSA officers face second missed paycheck in shutdown
The Trump administration said it plans to send ICE officers to help ease airport congestion amid TSA officer absences as they face second missed full...
The price of menstrual products is skyrocketing from inflation, tariffs
With rising inflation and changing tariff policies, menstrual products have seen a drastic rise in price over the past few years....
Nissan’s new hybrid is a U.S.-first that mixes EV driving with a gas engine
Nissan plans to introduce a new type of hybrid for the U.S. market that drives like an all-electric vehicle but is powered by a traditional...
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses....
The spring housing market is on, but mortgage rates just shot higher. Here’s what to know.
This spring’s housing market is on, but economic headwinds are pushing back most of the advantage that buyers have gained over the past year in...
Nexstar, Tegna merger closes after winning regulatory approval
Nexstar has closed its $6.2 billion acquisition of Tegna after winning approval from the Federal Communications Commission and Department of Justice....
FedEx beats on top and bottom lines, raises guidance on strong performance
FedEx posted strong fiscal third quarter results on Thursday and raised its guidance following a strong performance....
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial....